BioSpace News Archive

Aptose Biosciences Inc. announced today that the company management team will provide a clinical update on Saturday, June 10, 2023, at 12:00 PM EST / 6:00 PM CEST.

Liberate Bio., a biotech company focused on identifying and developing new vehicles to deliver oligonucleotide cargos, announced the expansion of its leadership team.

scPharmaceuticals Inc. announced that John Tucker, President & Chief Executive Officer, is scheduled to present at the Jefferies Healthcare Conference, which is being held June 7-9 in New York.

AltruBio Inc. announced that President and Chief Executive Officer Judy Chou, Ph.D., will present an in-person corporate overview at the 2023 BIO International Convention taking place June 5-8, 2023, in Boston, MA.

Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will participate in three investor conferences in June.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) today announced several CAPLYTA data presentations at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting being held in Miami, May 30 - June 2, 2023.

Reneo Pharmaceuticals, Inc. announced that the company’s management team will participate at the Jefferies Healthcare Conference.

Shockwave Medical, Inc. released its 2022 ESG Report highlighting accomplishments in environmental, social, and governance across its global markets.

Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2 clinical trials, announced that the Company will participate in the 2023 BIO International Convention held June 5-8, 2023 in Boston and the Jefferies Healthcare Conference held June 7-9, 2023 in New York City.

NewAmsterdam Pharma Company N.V. announced that Michael Davidson, M.D., chief executive officer of NewAmsterdam Pharma, will present at the Jefferies Healthcare Conference on Wednesday, June 7, 2023 at 3:30 p.m. ET.